Simulations Plus, Inc. (SLP)
NASDAQ: SLP · Real-Time Price · USD
29.75
-1.15 (-3.72%)
Oct 29, 2024, 4:00 PM EDT - Market closed

Simulations Plus Revenue

In the fiscal year ending August 31, 2024, Simulations Plus had annual revenue of $70.01M with 17.52% growth. Simulations Plus had revenue of $18.70M in the quarter ending August 31, 2024, with 19.65% growth.

Revenue (ttm)
$70.01M
Revenue Growth
+17.52%
P/S Ratio
8.49
Revenue / Employee
$355,396
Employees
197
Market Cap
596.52M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Aug 31, 202470.01M10.44M17.52%
Aug 31, 202359.58M5.67M10.52%
Aug 31, 202253.91M7.44M16.01%
Aug 31, 202146.47M4.88M11.73%
Aug 31, 202041.59M7.62M22.43%
Aug 31, 2019 Pro Pro Pro
Aug 31, 2018 Pro Pro Pro
Aug 31, 2017 Pro Pro Pro
Aug 31, 2016 Pro Pro Pro
Aug 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Orthofix Medical 771.65M
Pharming Group 285.75M
Entrada Therapeutics 239.40M
Cytek Biosciences 197.71M
OrthoPediatrics 175.07M
Standard BioTools 136.30M
CureVac 70.57M
Stoke Therapeutics 15.16M
Revenue Rankings